Featuring: Matthew L. Goodwin, MD, PHD (Washington University), Dan Sciubba, MD (Johns Hopkins), and Joe Schwab, MD, MS (Harvard/Massachusetts General Hospital)

Use of bone cement in the spine has been marred by early controversy, including debate over kyphoplasty/vertebroplasty and whether use of bone cement in spine surgery was safe or effective.  Now with recent publications reviewing almost 20 years of cement use in the spine, the data are relatively convincing that bone cement in spine surgery is not only useful, but also relatively safe.  

In this podcast, these spine tumor surgeons from NASS' Section on Spine Oncology discuss the history of bone cement in the spine, the current use/indications for cement (e.g. metastatic spinal disease, osteoporosis), current techniques (e.g. through fenestrated pedicle screws), and discuss potential complications as well as practical tips for employing these techniques.

Disclosures:

Goodwin, Matthew L.: Consulting: Augmedics (A); Fellowship Support: AO Spine  (Salary, Fellowship Support), NREF (Salary, Fellowship Support); Royalties: Kendall Hunt (B); Stock Ownership: ROM3 (200 Shares, Outside 12-Month Requirement).

Sciubba, Daniel M.: Consulting: Baxter (B), DePuy-Synthes (B), Globus (B), Medtronic (C), Nuvasive (B), Stryker (C).

Schwab, Joseph H.: Scientific Advisory Board: Chordoma Foundation (Nonfinancial); Speaking and/or Teaching Arrangements: AO Spine (Travel Expense Reimbursement, Outside 12-Month Requirement), Stryker Spine (B, Outside 12-Month Requirement).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+